OXON at CTS sharing a new method to boost trial and RWE study efficiency
November 28-29, 2024 | Barcelona
OXON will support CTS 2024 as an exhibitor, showcasing expanded services and new developments in RWE.
OXON’s Epidemiology will be at the 9th Clinical Trial Summit in Barcelona to share how our Real-World Evidence (RWE)-driven clinical trial services and new developments can support clinical research needs and optimize drug development programs across all phases (I-IV).
At Booth #E3 our team will share best practices with biotech and pharma companies, supporting them with our expanded services, designs and new developments.
- Leadership in Integrating RWE, Clinical Trials, and Meta-Analysis: OXON is at the forefront of combining Real-World Evidence (RWE), clinical trials, and meta-analysis to drive innovation and efficiency.
- Unmatched Expertise: Our team includes members who have co-authored 100+ publications in top journals such as NEJM and Lancet.
- Revolutionary Methodology: We are implementing the FDA/EMA-approved Win Ratio methodology, developed in collaboration with the inventor, to enhance the power and efficiency of trials and RWE studies.
And, if you are attending, do not miss our presentation on Day 1:
“Trials and External Controls in Rare Diseases: Strategy, Science, Regulators, and HTAs”